Literature DB >> 2781586

Dissociation of catalytic activity and neurotoxicity of a basic phospholipase A2 from Russell's viper (Vipera russelli) venom.

G P Jayanthi1, S Kasturi, T V Gowda.   

Abstract

A neurotoxic phospholipase A2, VRV PL-V was purified from Vipera russelli venom in a single step by CM-Sephadex C-25 column chromatography. VRV PL-V is a basic PLA2 with a mol. wt of approximately 10,000. The lethal potency of VRV PL-V was greater than that of the crude V. russelli venom. VRV PL-V showed anticoagulant activity and induced edema in the foot pad of the mouse. VRV PL-V undergoes aggregation at pH 4.8. The size of the aggregate increased as the temperature at which the enzyme was incubated was raised. A highly aggregated form with a mol. wt of 53,100 was formed at 96 degrees C. This aggregate showed a two-fold increase in its catalytic activity, while its neurotoxic activity disappeared. The aggregate also showed a significant increase in its anticoagulant activity when compared to the monomeric form. Edema-inducing activity decreased upon association to higher molecular form.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2781586     DOI: 10.1016/0041-0101(89)90099-8

Source DB:  PubMed          Journal:  Toxicon        ISSN: 0041-0101            Impact factor:   3.033


  3 in total

1.  Neurotoxicity in Sri Lankan Russell's Viper (Daboia russelii) Envenoming is Primarily due to U1-viperitoxin-Dr1a, a Pre-Synaptic Neurotoxin.

Authors:  Anjana Silva; Sanjaya Kuruppu; Iekhsan Othman; Robert J A Goode; Wayne C Hodgson; Geoffrey K Isbister
Journal:  Neurotox Res       Date:  2016-07-11       Impact factor: 3.911

2.  Antibodies to a phospholipase A2 from Vipera russelli selectively neutralize venom neurotoxicity.

Authors:  S Kasturi; L M Rudrammaji; T V Gowda
Journal:  Immunology       Date:  1990-06       Impact factor: 7.397

3.  A One Pot Synthesis of Novel Bioactive Tri-Substitute-Condensed-Imidazopyridines that Targets Snake Venom Phospholipase A2.

Authors:  Nirvanappa C Anilkumar; Mahalingam S Sundaram; Chakrabhavi Dhananjaya Mohan; Shobith Rangappa; Krishna C Bulusu; Julian E Fuchs; Kesturu S Girish; Andreas Bender; Kanchugarakoppal S Rangappa
Journal:  PLoS One       Date:  2015-07-21       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.